Tonix Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TNXP and other ETFs, options, and stocks.

About TNXP

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800.

CEO

Seth Lederman

CEOSeth Lederman

Employees

Employees81

Headquarters

Chatham, New Jersey

HeadquartersChatham, New Jersey

Founded

2007

Founded2007

Employees

Employees81

TNXP Key Statistics

Market cap

300.32M

Market cap300.32M

Price-Earnings ratio

-0.01

Price-Earnings ratio-0.01

Dividend yield

—

Dividend yield—

Average volume

814.14K

Average volume814.14K

High today

$42.74

High today$42.74

Low today

$38.87

Low today$38.87

Open price

$41.99

Open price$41.99

Volume

614.66K

Volume614.66K

52 Week high

$130.00

52 Week high$130.00

52 Week low

$6.76

52 Week low$6.76

TNXP News

TipRanks 2d

Tonix Pharma Publishes Phase 3 Trial Results

Don’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...

TipRanks 5d

Tonix Pharmaceuticals to present on Mpox, smallpox vaccine candidate TNX-801

Tonix Pharmaceuticals (TNXP) announced that Sina Bavari, PhD, Executive Vice President of Infectious Disease Research and Development at Tonix Pharmaceuticals,...

People also own

Based on the portfolios of people who own TNXP. This list is generated using Robinhood data, and it’s not a recommendation.